Francesca Maestrelli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Francesca Maestrelli has a total of 138 co-authors. Here are the top co-authors by number of shared publications:
- Paola Mura
Department of Chemistry (DICUS), School of Sciences of Human Health, University of Florence, Via Ugo Schiff, 6, Sesto F.no, 50019 Florence, Italy
37 shared publications - Marzia Cirri
Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
29 shared publications - Natascia Mennini
Department of Chemistry, School of Sciences of Human Health, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
20 shared publications - Carla Ghelardini
Department of Neuroscience, Psychology, Drug Research and Child Health—NEUROFARBA—Pharmacology and Toxicology Section University of Florence Florence Italy
9 shared publications - Antonio Maria Rabasco
Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, C/Prof. García González 2, 41012 Seville, Spain
6 shared publications - Giulia Nerli
Department of Chemistry, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy
6 shared publications
Latest Publications
- Open Access
Development and Characterization of a Dual-Drug Thermosensitive Mucoadhesive Hydrogel for the Local Treatment of Pediatric Oral Mucositis
Severe oral mucositis requires local treatments that relieve pain, limit microbial proliferation, and support mucosal repair while minimizing exposure to potentially harmful excipients, particularly in pediatric patients. This study aimed to develop thermosensitive mucoadhesive gels co-loaded with lidocaine hydrochloride (2% w/v) and chlorhexidine digluconate (0.2% w/v) for localized buccal therapy. Poloxamer 407 was combined with hyaluronic acid sodium salt, xanthan gum, Carbopol 934, or hydroxypropylmethylcellulose (HPMC). Formulations containing lidocaine alone or both drugs were compared to assess the influence of chlorhexidine addition. Following preliminary screening based on pH and gelation properties, selected formulations were characterized for technological, mucoadhesive, biopharmaceutical, stability, and antibacterial properties. Poloxamer 407 concentration was the main factor governing gel performance, whereas the mucoadhesive polymer primarily affected specific technological attributes. Chlorhexidine incorporation did not compromise overall gel performance, preserving antibacterial activity. The gels exhibited suitable gelation, spreadability, mucoadhesion, residence time, and release properties with negligible membrane permeation. The dual-drug formulation containing 20% poloxamer 407 and 0.50% HPMC emerged as the most promising one, combining appropriate mechanical properties, drug release, antibacterial efficacy, and storage stability. Overall, these findings support dual-drug thermosensitive mucoadhesive gels as a feasible strategy for the local management of severe oral mucositis, especially in pediatrics.
Open AccessDevelopment and Characterization of a Dual-Drug Thermosensitive Mucoadhesive Hydrogel for the Local Treatment of Pediatric Oral Mucositis
Severe oral mucositis requires local treatments that relieve pain, limit microbial proliferation, and support mucosal repair while minimizing exposure to potentially harmful excipients, particularly in pediatric patients. This study aimed to develop thermosensitive mucoadhesive gels co-loaded with lidocaine hydrochloride (2% w/v) and chlorhexidine digluconate (0.2% w/v) for localized buccal therapy. Poloxamer 407 was combined with hyaluronic acid sodium salt, xanthan gum, Carbopol 934, or hydroxypropylmethylcellulose (HPMC). Formulations containing lidocaine alone or both drugs were compared to assess the influence of chlorhexidine addition. Following preliminary screening based on pH and gelation properties, selected formulations were characterized for technological, mucoadhesive, biopharmaceutical, stability, and antibacterial properties. Poloxamer 407 concentration was the main factor governing gel performance, whereas the mucoadhesive polymer primarily affected specific technological attributes. Chlorhexidine incorporation did not compromise overall gel performance, preserving antibacterial activity. The gels exhibited suitable gelation, spreadability, mucoadhesion, residence time, and release properties with negligible membrane permeation. The dual-drug formulation containing 20% poloxamer 407 and 0.50% HPMC emerged as the most promising one, combining appropriate mechanical properties, drug release, antibacterial efficacy, and storage stability. Overall, these findings support dual-drug thermosensitive mucoadhesive gels as a feasible strategy for the local management of severe oral mucositis, especially in pediatrics.
- Open Access
- 29 March 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 697, 126821
Newly customized cationic ẞ-cyclodextrins as potential nanovectors for gene delivery
- 29 March 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 697, 126821
Open AccessNewly customized cationic ẞ-cyclodextrins as potential nanovectors for gene delivery
- Open Access
- 21 February 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 265
Non-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represent a therapeutic challenge, though very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical versatility make them powerful building blocks for the design of supramolecular nanovectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this context, CD-based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for siRNA delivery, discussing the role played by structural differences and chemical functionalization in the context of encapsulation and release.
- 21 February 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (2) , 265
Open AccessNon-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represent a therapeutic challenge, though very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical versatility make them powerful building blocks for the design of supramolecular nanovectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this context, CD-based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for siRNA delivery, discussing the role played by structural differences and chemical functionalization in the context of encapsulation and release.
- 18 February 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 119
Caffeic acid phenethyl ester and its micro- and nanoformulations with anticancer activities
- 18 February 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 119
Caffeic acid phenethyl ester and its micro- and nanoformulations with anticancer activities
- Open Access
- 21 January 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 117
Development and characterization of orally disintegrating films of Nebivolol as complex with Sulfobutylether-β-cyclodextrin
- 21 January 2026
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 117
Open AccessDevelopment and characterization of orally disintegrating films of Nebivolol as complex with Sulfobutylether-β-cyclodextrin
- Open Access
- 24 November 2025
- Published by MDPI AG in Preprints.org
Non-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represents a therapeutic challenge and very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical ver-satility make them powerful building blocks for the design of supramolecular nano-vectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this contest CD based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery systems. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for delivery of siRNA, discussing the ins and outs of structural differences and chemical functionalization.
- 24 November 2025
- Published by MDPI AG in Preprints.org
Open AccessNon-Viral Nanovectors Based on Cyclodextrins for siRNA Delivery: An Update to Current Technologies
Gene delivery/administration and, in particular, small interfering RNA (siRNA) delivery represents a therapeutic challenge and very effective carriers have yet to be identified. Cyclodextrins (CDs) are cyclic oligosaccharides with unique host–guest inclusion capabilities, widely recognized in the pharmaceutical field for their ability to enhance drug solubility and bioavailability. Their excellent biocompatibility and chemical ver-satility make them powerful building blocks for the design of supramolecular nano-vectors (NVs). Thanks to their facility of functionalization, CDs are highly versatile and have found numerous applications across various fields. In this contest CD based NVs are currently explored as non-viral agents to transport and release siRNA. Recent studies suggest that self-assembled NVs based on CDs can improve the transfection and safety of siRNA delivery systems. This review provides a comprehensive overview of the most recent advances in the design of NVs based on CDs and their use for delivery of siRNA, discussing the ins and outs of structural differences and chemical functionalization.
- Open Access
- 5 July 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 682, 125933
Curcumin’s niosomes coated with chitosan for the treatment of osteoarthritis: effect of cyclodextrin complexation
- 5 July 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 682, 125933
Open AccessCurcumin’s niosomes coated with chitosan for the treatment of osteoarthritis: effect of cyclodextrin complexation
- Open Access
- 14 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Mucin 1 Antigen Mimetic Functionalized Mannosylated Peptide Nanofibers for Antigen Uptake and Immune Modulation
In this work, immune modulation of the monocyte-derived dendritic cells was studied by in vitro cell culture and organ-on-chip models. Self-assembled mannosylated peptide nanofibers were prepared and integrated with the MUC1 TnThr mimetic Tn-MIM to stimulate DCs’ maturation and differentiation. Man-PA/Tn-MIM nanofibers displayed remarkable cell-penetrating capabilities, also allowing the correct presentation of the antigen mimetic with a corresponding induction of lymphocytes, iNKT and NK cells recruitment. The Tn-MIM integrated nanofibrers were also found to direct immune response towards Th1 phenotype which is responsible for the production of cellular and humoral immunity. Organ-on-chip tests confirmed the cytotoxicity of lymphocytes stimulated with DC exposed to Man-PA/Tn-MIM. These results will help in the development of immunotherapies avoiding complications due to heterogeneous antigen display and to the use of adjuvants.
- 14 May 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessMucin 1 Antigen Mimetic Functionalized Mannosylated Peptide Nanofibers for Antigen Uptake and Immune Modulation
In this work, immune modulation of the monocyte-derived dendritic cells was studied by in vitro cell culture and organ-on-chip models. Self-assembled mannosylated peptide nanofibers were prepared and integrated with the MUC1 TnThr mimetic Tn-MIM to stimulate DCs’ maturation and differentiation. Man-PA/Tn-MIM nanofibers displayed remarkable cell-penetrating capabilities, also allowing the correct presentation of the antigen mimetic with a corresponding induction of lymphocytes, iNKT and NK cells recruitment. The Tn-MIM integrated nanofibrers were also found to direct immune response towards Th1 phenotype which is responsible for the production of cellular and humoral immunity. Organ-on-chip tests confirmed the cytotoxicity of lymphocytes stimulated with DC exposed to Man-PA/Tn-MIM. These results will help in the development of immunotherapies avoiding complications due to heterogeneous antigen display and to the use of adjuvants.
- Open Access
- 19 November 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 668, 124972
Cyclodextrin complexation as a fruitful strategy for improving the performance of nebivolol delivery from solid lipid nanoparticles
- 19 November 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 668, 124972
Open AccessCyclodextrin complexation as a fruitful strategy for improving the performance of nebivolol delivery from solid lipid nanoparticles